WHO ICTRP trial

A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Trial to…

EUCTR2006-000006-23-HU · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2006-000006-23-HU
Public title A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin in Combination with Metformin IR as Initial Therapy Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Subjects with Type 2 Diabetes Who Have Inadequate Glycemic Control. Pharmacogenetics Blood Sample Amendment Number 01 - Site Specific
Scientific title A Multicenter, Randomized, Double-Blind, Active-Controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Saxagliptin in Combination with Metformin IR as Initial Therapy Compared to Saxagliptin Monotherapy and to Metformin IR Monotherapy in Subjects with Type 2 Diabetes Who Have Inadequate…
Primary sponsor Bristol-Myers Squibb International Corporation
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries Hungary;Germany;Italy
Conditions Type 2 Diabetes Mellitus
Interventions Product Name: Saxagliptin Product Code: BMS-477118-11 Pharmaceutical Form: Film-coated tablet INN or Proposed INN: Saxagliptin CAS Number: 361442-04-8 Current Sponsor code: BMS-477118-11 Concentration unit: mg milligram(s) Concentration…
Registration date Sep 20, 2006
Target size 2940
Secondary IDs CV181039
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations